FDA approval for Omlyclo (omalizumab-igec) as the first biosimilar to reference Xolair (omalizumab) – Celltrion
The FDA announced the approval of Omlyclo (omalizumab-igec) as the first biosimilar to reference Xolair (omalizumab). The biosimilar was also approved with interchangeability status and is the first… read more.
